Meridian Life Science, Inc.

Last week, the Centers for Disease Control and Prevention published the October update for the 2024-2025 Respiratory Disease Season Outlook (https://lnkd.in/eR7XQxuX). They predict a similar number of hospitalizations in comparison to last year but are preparing for various scenarios. Currently, respiratory virus activity remains low nationwide, with declining COVID-19 cases and low flu and RSV activity. Meridian’s paired antibodies for Flu A, Flu B, SARS-CoV-2, and RSV are designed for rapid lateral flow assays and are ideal for multiplex tests to distinguish flu, COVID-19, and RSV. Download our informational sheet to learn more: https://lnkd.in/gDYWhrJV #moleculardiagnostics #pointofcare #respiratorydisease #COVID #RSV

Join us at ASHG 2024 (Nov 5th - 9th), where our Senior Manager of R&D, Michele Amasio, Ph.D., will present his talk on “Revolutionizing Next Generation Sequencing Accessibility by Innovating Reagent Logistics.”  Discover the technological advancements in NGS chemistries that are increasing the affordability, accessibility and sustainability of NGS and how Meridian's new glycerol-free enzymes are being used to enable lyophilization of the library preparation and amplification kits! Time/Date: Thursday, November 7th @ 12:45 – 1:15pm Location:   CoLab Theater 1 Or drop by our booth #385 to speak to a technical representative! https://ow.ly/CBNc50TNzuU Eiland Stebly Lucy Allen Pillai Cheryl Paes Dale Clash Michele Amasio #molecularinnovation #ngs #ashg2024 #PCRtechnology #sustainability #lyophilization

Join us for our webinar on “Increasing Access to Point-of-Care Diagnostics Through Innovative Advances in Molecular Reagents for Assay Development”, taking place November 20th @ 3pm London time! Point-of-care (POC) assays are gaining significant traction in diagnostic testing; however, these tests face challenges related to accessibility, stability, and ease of workflow. Due to infrastructure limitations, especially in remote areas, there is often a lack of necessary resources for appropriately storing reagents, and complex workflows are frequently difficult to implement in non-laboratory settings. Join our webinar to learn about: • Innovative molecular reagents that simplify assay workflow using direct detection • Benefits to eliminating cold-chain through ambient temperature assay stability • Advances in qPCR and isothermal technologies tailored for point-of-care use Register here: https://lnkd.in/d_pypxUW Lina Gasiūnaitė Steve Hawkins #webinar #pointofcaretesting #isothermalamplificiation #moleculardiagnostics

You’re invited to join our newsletter! “Diagnostics Dialogue”: where our experts come together to explore the latest trends, breakthroughs, and products in the field –- each edition is curated to keep you at the forefront of advancements in diagnostics. By subscribing to Diagnostics Dialogue, you'll gain exclusive access to: 🔍 In-depth articles by experts 📈 Insights into market trends and forecasts 💡 Updates on Meridian's latest innovations and offerings 📰 And much more! Don't miss out on this exciting opportunity to join the conversation. Subscribe today and let's embark on this journey of discovery together! Click here to subscribe: https://lnkd.in/gzVukGAV

Join us at AMP 2024 (Nov 21st – 23rd), where our Senior Manager of R&D, Michele Amasio, Ph.D., will present his talk on “Advancing Oncology Diagnostics: Innovative Molecular Reagents for Patient-Centric Testing.”  Discover the latest molecular reagent solutions that advance point-of-care (POC) applications. From glycerol-free enzymes to lyophilization-ready master mixes for LAMP and qPCR, Meridian’s solutions support sustainable POC assay development that can increase the efficiency and accessibility of your assays. For more details or to book a meeting, visit: https://lnkd.in/ePtk_BTi. We look forward to seeing you there! Eiland Stebly Dale Clash Chris Boyd Michele Amasio #molecularinnovation #pointofcare #amp2024 #isothermalamplification #sustainability

We look forward to seeing you at MEDICA, November 11th – 14th in Duesseldorf, Germany! Stop by booth #3D19-1 to meet our experts and discover the latest innovations in sustainable molecular and immunology assays. Learn how our solutions can streamline your workflow, enhance assay efficiency, and lower costs—all while promoting eco-conscious practices. Or plan ahead and schedule a meeting with one of our technical delegates! CLICK HERE to book a meeting: https://lnkd.in/ehhgcgjV Alpha Chen Nick Bates Steve Hawkins Reni Lam Paul Marr #moleculardiagnostics #infectiousdiseasediagnostics #MEDICA2024

IgM detection assays are valuable diagnostic tools in identifying primary infections, however, IgM antibodies only comprise 5-10% of the total antibody population in circulation. In order to accurately measure IgM, it is necessary to reduce assay interference caused by more prevalent IgG antibodies. Meridian manufactures thousands of liters per year of purified goat anti-human IgG Fc fragment (GAH IgG Fc, Cat# L15406G), and ready-to-use IgM Assay Diluent (Cat# 8120). These are IgG absorbents designed to remove human IgG and IgG/rheumatoid factor (RF) complexes from serum prior to IgM testing by CLIA, ELISA, LF, nephelometry or turbidometry. They are not cross-reactive with human IgM, IgA, or other non-immunoglobin serum proteins. Click here to order a sample today:https://lnkd.in/gMQZZbGG #Assaydevelopment #immunoassay #diagnostics

Join us for our webinar on “Increasing Access to Point-of-Care Diagnostics Through Innovative Advances in Molecular Reagents for Assay Development”, taking place November 20th @3pm London time! Point-of-care (POC) assays are gaining significant traction in diagnostic testing; however, these tests face challenges related to accessibility, stability, and ease of workflow. Due to infrastructure limitations, especially in remote areas, there is often a lack of necessary resources for appropriately storing reagents, and complex workflows are frequently difficult to implement in non-laboratory settings. Join our webinar to learn about: • Innovative molecular reagents that simplify assay workflow using direct detection • Benefits to eliminating cold-chain through ambient temperature assay stability • Advances in qPCR and isothermal technologies tailored for point-of-care use Register here: https://lnkd.in/d_pypxUW Lina Gasiūnaitė Steve Hawkins #webinar #pointofcaretesting #isothermalamplificiation #moleculardiagnostics

Set your NGS assays FREE from cold-chain! Meridian launches the first Lyophilized NGS Library Preparation kit, setting a new standard in convenience and innovation! Click here to learn more: https://lnkd.in/eP_bDs7r #NextGenerationSequencing #sustainableinnovation

The evolving landscape of the point-of-care testing (POCT) market is being driven by: (1) technological advancements (2) increasing demand for faster results (3) the need for more efficient and patient-centered healthcare solutions Meridian’s Specimen-specific™ LAMP master mixes and BST enzymes are ideal for high-sensitivity LAMP assays. They are inhibitor-tolerant and can amplify DNA directly from crude samples such as blood, urine, saliva and stool, or from extracted DNA. In addition, the mixes can be lyophilized or air-dried to create room-temperature stable assays, which is essential for reducing cold chain management of POCTs. Learn more: https://lnkd.in/eEmjbQRk #moleculardiagnostics #pointofcaretesting #innovation